MeSH D001932 - brain neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| A.H. Robins Company | Methylprednisolone | Methylprednisolone |  | 1982-01-01 |  |  |
| Prednisolone | Prednisolone |  | 1982-01-01 |  |  | |
| Abbott Biotherapeutics | Methylprednisolone | A-methapred |  | 1991-02-22 |  |  |
| AbbVie | Prednisolone | Pred |  | 1982-01-01 |  |  |
| Prednisolone | Pred Mild |  | 1982-01-01 |  |  | |
| Accord Healthcare | Carmustine | Carmustine |  | 2022-12-27 |  |  |
| Etoposide | Etoposide |  | 1996-03-14 |  |  | |
| Alcon Research | Prednisolone, Sulfacetamide | Cetapred |  | 1993-08-06 |  |  |
| Prednisolone, Sulfacetamide | Isopto Cetapred |  | 1982-01-01 |  |  | |
| Prednisolone | Prednisolone |  | 1991-10-24 |  |  | |
| Alembic Pharmaceuticals | Carmustine | Carmustine |  | 2023-10-20 |  |  |
| Allergan | Prednisolone, Sulfacetamide | Blephamide |  | 1986-12-03 |  |  |
| Prednisolone, Chloramphenicol | Chloroptic-p |  | 1982-01-01 |  |  | |
| Prednisolone, Neomycin, Polymyxin b | Poly-pred |  | 1982-01-01 |  |  | |
| Prednisolone, Gentamicin | Pred |  | 1988-06-10 |  |  | |
| Etoposide | Etoposide |  | 1996-10-15 |  |  | |
| Methylprednisolone | Methylprednisolone |  | 1997-10-16 |  |  | |
| Prednisolone | Prednisolone |  | 1982-01-01 |  |  | |
| Prednisolone tebutate | Prednisolone Tebutate |  | 1984-02-17 |  |  | |
| Amneal Pharmaceuticals | Carmustine | Carmustine |  | 2018-10-16 |  |  |
| Methylprednisolone | Methylprednisolone |  | 2021-09-21 |  |  | |
| Prednisolone | Prednisolone |  | 2009-03-10 |  |  | |
| APP Pharmaceuticals | Methylprednisolone | Methylprednisolone |  | 1984-06-08 |  |  |
| Aurobindo Pharma | Prednisolone | Prednisolone |  | 2023-03-17 |  |  |
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
58%94/163
Phase 2
29%48/163
Phase 3
31%23/75
Approved: 14Overall Success rate: 5%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
7
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use